{"nct_id":"NCT00205478","title":"Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702","status":"COMPLETED","status_verified_date":"2007-12","start_date":"2005-06","start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":"2006-02","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["VRTX"]}